Jonna is a member of the Aurevia Management team and reports to Aurevia CEO Juha-Pekka Nuutinen. Aurevia’s EQA team offers clinically relevant external quality assessment schemes (EQAS) for medical laboratories and point-of-care testing sites to monitor and improve their performance and quality.
Jonna holds a Master of Science in Technology degree from the Helsinki University of Technology and a Clinical Biochemist degree from the Faculty of Medicine at the University of Helsinki. She is also dedicated to advancing her PhD research at the University of Helsinki’s Faculty of Medicine, focusing on “Improving Diagnostic Testing Quality through Meaningful Data Mining”. Since joining Aurevia in 2010, Jonna has held several positions in the company, including EQA Coordinator, Head of EQA Production, Head of ICT, and Head of R&D. Jonna has played a pivotal role in advancing laboratory quality and developing Aurevia’s digital EQA platform LabScala.
“I’m happy to nominate Jonna Pelanti, a distinguished leader in clinical laboratory medicine, as our new Head of EQA business area. She has the right experience and expertise to lead and maintain the current solid growth of our EQA business. Moreover, she can support accelerating business growth by developing new innovative solutions with her team. I’m confident that Jonna will succeed in her new role as she combines strong business acumen with a passion to optimize external quality assessment. She is also committed to utilizing modern technologies and data-driven insights in her work,” says CEO Juha-Pekka Nuutinen from Aurevia.
“It is an honor to lead the excellent Aurevia EQA team. I believe in the power of teamwork, and I highly value the expertise and dedication of my colleagues at Aurevia across different laboratory medicine fields, client services, sales, and logistics. I’m also an advocate for strong collaboration between international EQA providers, healthcare institutions, and industry partners. By working together with our own EQA team and external experts and partners, I’m fully committed to leading Aurevia’s EQA services to new heights and ensuring continuous improvement and innovation in laboratory quality assessment worldwide,” concludes Jonna Pelanti.
Jonna started in her new role on February 1, 2025.
For queries, please contact:
Juha-Pekka Nuutinen
CEO | Aurevia
+358 40 828 3210 | juha-pekka.nuutinen@aurevia.com
AUREVIA
As Aurevians, we are the excellence makers: a team of experienced experts in healthcare and health-tech standards and quality. Together, we advance healthcare, pharmaceutical and medical technology development with a future-focused approach, aligned with client needs. Driven by our commitment to care, we contribute quality to the industry and pave the way for safer, more effective patient care worldwide.
We are a full-service, rapid-response Contract Research Organization (CRO) and external quality assessment services (EQAS) provider. Our quality services for the healthcare, pharmaceutical, and medical technology industries cover external quality assessments, quality assurance, regulatory affairs, clinical investigations and trials, audits and certifications, and training. Our expertise and knowledge benefit medical device and in vitro diagnostic manufacturers, pharmaceutical companies, healthcare units, and clinical laboratories.
Currently, we serve over 8000 customers in over 60 countries around the world. Our team comprises nearly 200 skilled professionals in offices in Finland, Sweden, Poland, and Germany. Aurevia is supported by Mérieux Equity Partners.
Aurevia – empowering clients with excellence-driven solutions to achieve the highest standards in patient care.